NasdaqGM - Nasdaq Real Time Price USD
Kalaris Therapeutics, Inc. (KLRS)
2.8300
-0.1500
(-5.03%)
At close: May 22 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
Total Revenue
0
0
0
Operating Expense
48,063
13,464
14,006
Operating Income
-48,063
-13,464
-14,006
Net Non Operating Interest Income Expense
-1,431
-687
-235
Other Income Expense
-1,118
-548
-1,244
Pretax Income
-50,612
-14,699
-15,485
Net Income Common Stockholders
-50,612
-14,699
-15,485
Diluted NI Available to Com Stockholders
-50,612
-14,699
-15,485
Basic EPS
-2.71
-0.79
-0.83
Diluted EPS
-2.71
-0.79
-0.83
Basic Average Shares
18,702.4130
18,702.4130
18,702.4130
Diluted Average Shares
18,702.4130
18,702.4130
18,702.4130
Total Operating Income as Reported
-48,063
-13,464
-14,006
Total Expenses
48,063
13,464
14,006
Net Income from Continuing & Discontinued Operation
-50,612
-14,699
-15,485
Normalized Income
-51,472
-15,006
-16,028
Interest Expense
1,431
687
235
Net Interest Income
-1,431
-687
-235
EBIT
-49,181
-14,012
-15,250
EBITDA
-49,181
-14,012
-15,250
Net Income from Continuing Operation Net Minority Interest
-50,612
-14,699
-15,485
Total Unusual Items Excluding Goodwill
860
307
543
Total Unusual Items
860
307
543
Normalized EBITDA
-50,041
-14,319
-15,793
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2022 - 7/30/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SER Serina Therapeutics, Inc.
5.89
+8.87%
LIMN Liminatus Pharma, Inc.
5.50
-10.57%
KLTO Klotho Neurosciences, Inc.
0.1890
+5.00%
ICCC ImmuCell Corporation
6.18
+0.65%
ZURA Zura Bio Limited
1.0400
+0.97%
APLM Apollomics, Inc.
7.26
+3.13%
4565.T Nxera Pharma Co., Ltd.
818.00
+1.74%
SABS SAB Biotherapeutics, Inc.
1.8600
+8.77%
HOOK HOOKIPA Pharma Inc.
1.6200
+6.58%
CTNM Contineum Therapeutics, Inc.
3.9100
+1.43%